Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment | |
Lang, Xiaoe2; Wang, Dongmei1,3; Chen, Dachun4; Xiu, Meihong4; Zhou, Huixia1,3; Wang, Li1,3; Cao, Bo5; Zhang, Xiangyang1,3 | |
刊名 | NEUROTHERAPEUTICS |
2022-01-31 | |
通讯作者邮箱 | langxiaoe@yeah.net (xiaoe lang ) ; cloudbocao@gmail.com (bo cao ) ; zhangxy@psych.ac.cn (x. zhang)) |
页码 | 9 |
关键词 | Schizophrenia Hippocampus First-episode Risperidone Treatment Prediction |
ISSN号 | 1933-7213 |
DOI | 10.1007/s13311-021-01174-8 |
产权排序 | 2 |
文献子类 | 实证研究 |
英文摘要 | Small hippocampal size may be implicated in the pathogenesis and psychopathology of schizophrenia (SCZ). However, does the volume of hippocampal subfields in SCZ patients affect response to antipsychotic treatment? In this study, we used risperidone to treat first-episode drug naive (FEDN) SCZ patients for 12 weeks, and then explored the relationship between baseline hippocampal subfield volumes, as well as any changes in these hippocampal subfield volumes during treatment, and improvement in their psychopathological symptoms. By adopting a state-of the-art automated algorithm, the hippocampal subfields were segmented in 43 FEDN SCZ inpatients at baseline and after 12 weeks of risperidone monotherapy, as well as in 30 matched healthy controls. We adopted the Positive and Negative Syndrome Scale (PANSS) to assess psychopathological symptoms in patients at baseline and at post-treatment. Before treatment, SCZ patients had no significant differences in total or subfield hippocampal volumes compared with healthy volunteers. However, we found a significant correlation between a smaller left CA1 at baseline and a lower PANSS total score and general psychopathology sub-score at post-treatment (both p < 0.05). Furthermore, the left CA1 at baseline was significantly smaller in responders, who had >50% improvement in PANSS total score, than in non-responders (p < 0.05). Our results suggest that smaller left CA1 volume may be a predicator for improvement in psychotic symptoms of FEDN SCZ patients. |
收录类别 | SCI |
资助项目 | Key Research Project in Shanxi Province[201803D31098] ; Wu Jieping Medical Foundation[320.6750.18336] ; CAS International Cooperation Research Program[153111KYSB20190004] |
WOS关键词 | ANTIPSYCHOTIC TREATMENT ; DENTATE GYRUS ; VOLUME ; RELIABILITY ; DYSFUNCTION ; PSYCHOSIS ; CA3 |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | SPRINGER |
WOS记录号 | WOS:000750485200002 |
资助机构 | Key Research Project in Shanxi Province ; Wu Jieping Medical Foundation ; CAS International Cooperation Research Program |
内容类型 | 期刊论文 |
源URL | [http://ir.psych.ac.cn/handle/311026/41918] |
专题 | 心理研究所_中国科学院心理健康重点实验室 |
通讯作者 | Lang, Xiaoe; Cao, Bo; Zhang, Xiangyang |
作者单位 | 1.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China 2.Shanxi Med Univ, Dept Psychiat, Hosp 1, Taiyuan, Peoples R China 3.Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing, Peoples R China 4.Peking Univ, Beijing HuiLongGuan Hosp, Beijing, Peoples R China 5.Univ Alberta, Fac Med & Dent, Dept Psychiat, Edmonton, AB T6G 2B7, Canada |
推荐引用方式 GB/T 7714 | Lang, Xiaoe,Wang, Dongmei,Chen, Dachun,et al. Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment[J]. NEUROTHERAPEUTICS,2022:9. |
APA | Lang, Xiaoe.,Wang, Dongmei.,Chen, Dachun.,Xiu, Meihong.,Zhou, Huixia.,...&Zhang, Xiangyang.(2022).Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment.NEUROTHERAPEUTICS,9. |
MLA | Lang, Xiaoe,et al."Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment".NEUROTHERAPEUTICS (2022):9. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论